Printer Friendly
The Free Library
19,585,944 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AlphaRx Announces Letter of Intent To Acquire Pharmaceutical Manufacturing Company.


Health/Medical Writers

RICHMOND HILL Richmond Hill may refer to:

Places:
Canada
  • Richmond Hill, Ontario
  • Richmond Hill (electoral district), a Federal constituency
United Kingdom
, Ontario--(BW HealthWire)--March 26, 2002

AlphaRx Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
: ALRX) announced today that it has signed a letter of intent to acquire all the stock of a privately held US pharmaceutical manufacturing company. The Company manufactures under contract and private label business, with over 200 vitamin and mineral supplements in its product line. Financials details of the proposed acquisition are not disclosed at this time. Deloitte and Touche Corporate Finance Canada Inc. will be advising the Company on the acquisition. The acquisition is expected to close in April of 2002.

"This acquisition supports AlphaRx's strategy on focusing on revenue growth, profit generation and operational improvements. It expedites the commercialization of our drug delivery technologies in the US as well as opening new business opportunities internationally. Opportunities for value creation are significant and the acquisition will immediately enhance underlying earnings," said Mr. Michael Lee Michael Lee may refer to:
  • Michael Lee (Australian politician)
  • Michael Lee (hockey player), a Canadian field hockey player
  • Michael Lee (keyboardist), keyboardist for Meredith Brooks and Melissa Etheridge
  • Michael Lee (musician), a drummer for Page and Plant
, President of AlphaRx.

"Our goal is to expand through strategic acquisitions. We believe this is the fastest way to introduce our drug delivery products to the worldwide market place. We are actively pursuing acquisition opportunities that will complement or extend our existing product lines or that would be compatible with our business philosophy and strategic goals. We believe that our leading medical and pharmaceutical research background and innovative product lines provide us with a strategic advantage in pursuing and consummating such opportunities," concluded Mr. Lee.

The acquisition is subject to certain closing conditions, including satisfactory completion of due diligence Research; analysis; your homework. This term has caught on in all industries, because it sounds so "wired." Who would want to do analysis or research when they can do due diligence. See wired.  and execution of the Definitive Agreement.

About AlphaRx

AlphaRx is engaged in the development of novel formulations of drugs that are insoluble insoluble /in·sol·u·ble/ (in-sol´u-b'l) not susceptible of being dissolved.

in·sol·u·ble
adj.
Not soluble.
 or poorly soluble in water. AlphaRx's broad product pipeline consists of carefully selected, currently marketed drugs which, through the application of its proprietary BCD (Binary Coded Decimal) The storage of numbers in which each decimal digit is converted into binary and is stored in a single character or byte. For example, a 12-digit number would take 12 bytes. See binary numbers.  drug delivery technology, offer improved medical benefits over existing products with a strong commercial potential.

FORWARD LOOKING STATEMENTS:

This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 provisions of the Securities Litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute.

When a person begins a civil lawsuit, the person enters into a process called litigation.
 Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1CANA
Date:Mar 26, 2002
Words:373
Previous Article:McCabe Launches the Industry's First Change-verification Tool for Enterprise Java Application Development, Release Rocket Verify, At The JavaOne...
Next Article:Ashton Mining of Canada, Inc.: Kikerk Lake Property Winter Program Underway.



Related Articles
AlphaRx Announces Favorable CoQ10 ER Clinical Trial Results.
AlphaRx Enters into Strategic Alliance With Taiwan PanBiotic to Commercialize BCD Drug Delivery Products in Taiwan.
AlphaRx Announces the Acquisition of a Controlling Interest in Taiwan PanBiotic Laboratories.
AlphaRx to Present at the 6th International Drug Delivery Technologies & Deal-Making Summit.
AlphaRx to Present Research Paper at the 28th International Symposium on Controlled Release of Bioactive Materials Conference.
AlphaRx Announces Share Consolidation.
AlphaRx Launches Comprehensive Investor Relations Campaign.
AlphaRx Positions Itself For Future Growth With Their Proprietary Drug Delivery Technology.
AlphaRx, Inc. Secures Private Placement Financing.
AlphaRx Announces Results On Highly Effective, Novel, Topical Non-Steroidal Anti-Inflammatory Formulations.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles